CorMedix Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Go back to CorMedix Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

CorMedix (CRMD) Tops Q4 EPS by 5c

March 25, 2025 8:20 AM EDT

CorMedix (NASDAQ: CRMD) reported Q4 EPS of $0.22, $0.05 better than the analyst estimate of $0.17. Revenue for the quarter came in at $31.2 million versus the consensus estimate of $31 million.

For earnings history and earnings-related data on CorMedix (CRMD) click here.

... More